Sichuan Baili Pharmaceutical

NCT07818499

Phase 1/2, Not yet recruiting, 2026, 204 people, 14 Sept 2026, clinicaltrials.gov

NCT07797881

Phase 2, Not yet recruiting, 2026, 60 people, 1 Sept 2026, clinicaltrials.gov

NCT07783321

Phase 3, Not yet recruiting, 2026, 404 people, 24 Aug 2026, clinicaltrials.gov

NCT07739199

Phase 2/3, Not yet recruiting, 2026, 200 people, 31 Jul 2026, clinicaltrials.gov

NCT07739186

Phase 2/3, Not yet recruiting, 2026, 120 people, 31 Jul 2026, clinicaltrials.gov

NCT07648914

Phase 3, Recruiting, 2026, 446 people, 15 Jun 2026, clinicaltrials.gov

NCT07642024

Phase 2/3, Recruiting, 2026, 90 people, 11 Jun 2026, clinicaltrials.gov

NCT07606599

Phase 3, Recruiting, 2026, 398 people, 26 May 2026, clinicaltrials.gov

NCT07582315

Phase 3, Recruiting, 2026, 538 people, 12 May 2026, clinicaltrials.gov

NCT07554456

Phase 2/3, Recruiting, 2026, 90 people, 28 Apr 2026, clinicaltrials.gov

NCT07545460

Phase 3, Not yet recruiting, 2026, 404 people, 22 Apr 2026, clinicaltrials.gov

NCT07518147

Phase 3, Recruiting, 2026, 438 people, 8 Apr 2026, clinicaltrials.gov

NCT07502300

Phase 3, Recruiting, 2026, 562 people, 30 Mar 2026, clinicaltrials.gov

NCT07255872

Phase 2/3, Recruiting, 2026, 216 people, 1 Dec 2025, clinicaltrials.gov

NCT07178795

Phase 3, Recruiting, 2025, 440 people, 17 Sept 2025, clinicaltrials.gov

NCT06957886

Phase 3, Recruiting, 2025, 566 people, 6 May 2025, clinicaltrials.gov

NCT06891833

Phase 2/3, Recruiting, 2025, 985 people, 24 Mar 2025, clinicaltrials.gov

NCT06304974

Phase 3, Active, not recruiting, 2024, 497 people, 12 Mar 2024, clinicaltrials.gov

NCT05054439

Phase 2, Active, not recruiting, 2021, 45 people, 23 Sept 2021, clinicaltrials.gov